Re: A few clarifications from IR
in response to
by
posted on
Mar 01, 2019 05:59PM
I agree, she really didn't answer this question.
Is reaching 250 adjudicated MACE events the trigger for end of dosing in BETonMACE?
We have stated that the trial will continue until 250+ narrow events have occurred, however we have not publicly disclosed adjudicated vs. nonadjudicated.